Tautona Group – Medium

Tautona Group

Published in
TauTonaMedia

TauTona’s Pullulan-Collagen Hydrogel Wound Dressing Promotes Dermal Remodelling

Great news from the wound healing world!

May 26, 2022

TauTona’s Pullulan-Collagen Hydrogel Wound Dressing Promotes Dermal Remodelling

May 26, 2022

Published in
TauTonaMedia

Theris Medical Launches Patient Enrollment for “Orphan Drug” Clinical Trial to Help…

We navigated a pandemic to enroll our first patient in a clinical trial to treat a very underserved patient group unaddressed by Big Pharma

Sep 15, 2020

Theris Medical Launches Patient Enrollment for “Orphan Drug” Clinical Trial to Help…

Sep 15, 2020

Published in
TauTonaMedia

TauTona Group Receives Orphan Disease Designation for Sickle Cell Ulcer Treatment

Changing the Standard of Care for Underserved Patients with Debilitating Wounds

May 16, 2020

TauTona Group Receives Orphan Disease Designation for Sickle Cell Ulcer Treatment

May 16, 2020

Published in
TauTonaMedia

TauTona Group Sells Surgical Marker Technology to Novadaq

The Surgical Marker is designed to work with select imaging procedures such as those done with Novadaq’s SPY Fluorescence Imaging System…

Apr 20, 2017

TauTona Group Sells Surgical Marker Technology to Novadaq

Apr 20, 2017

Published in
TauTonaMedia

‪Another Sale for TauTona Group

Allergan Buys Aline HA Thread Technology‬

Apr 19, 2017

‪Another Sale for TauTona Group

Apr 19, 2017

Published in
TauTonaMedia

TauTona Group Sells ‘Adipose Tissue Injector’ to LifeCell

Life Cell acquired an advanced adipose Tissue Injector (aTI) for improved fat grafting procedures from the TauTona Group.

Apr 19, 2017

TauTona Group Sells ‘Adipose Tissue Injector’ to LifeCell

Apr 19, 2017

Tautona Group

Tautona Group

Vertically-integrated #healthcare #VC creating solutions for unmet clinical need in #woundhealing, #diabeticfoot, #reconstructivesurgery & #regenerativemedicine

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams